STREAMEX CORP. Debt Instrument, Fee Amount
STREAMEX CORP. (STEX) had Debt Instrument, Fee Amount of $50.00 million as of 2026-02-06, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2026-05-14
- 2026-02-06: Debt Instrument, Fee Amount $50.00M.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2026-02-06 | $50.00M 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |